122 related articles for article (PubMed ID: 7564889)
1. Comparison of bronchodilator responses to adrenomedullin and proadrenomedullin N-terminal 20 peptide.
Kanazawa H; Kawaguchi T; Fujii T; Kudoh S; Hirata K; Kurihara N; Takeda T
Life Sci; 1995; 57(16):PL241-5. PubMed ID: 7564889
[TBL] [Abstract][Full Text] [Related]
2. Adrenomedullin, a newly discovered hypotensive peptide, is a potent bronchodilator.
Kanazawa H; Kurihara N; Hirata K; Kudoh S; Kawaguchi T; Takeda T
Biochem Biophys Res Commun; 1994 Nov; 205(1):251-4. PubMed ID: 7999032
[TBL] [Abstract][Full Text] [Related]
3. PAMP is a novel inhibitor of the tachykinin release in the airway of guinea pigs.
Kanazawa H; Kamoi H; Kawaguchi T; Shoji S; Fujii T; Kudoh S; Hirata K; Yoshikawa J
Am J Physiol; 1997 Jun; 272(6 Pt 1):L1066-9. PubMed ID: 9227505
[TBL] [Abstract][Full Text] [Related]
4. [Effect of adrenomedullin on bronchoconstriction responses induced by histamine].
Li S; Liu C; Guo D
Zhonghua Jie He He Hu Xi Za Zhi; 1998 Mar; 21(3):147-9. PubMed ID: 11263349
[TBL] [Abstract][Full Text] [Related]
5. Potentiation of the bronchoprotective effects of vasoactive intestinal peptide, isoprenaline, and theophylline against histamine challenge in anaesthetised guinea pigs by adrenomedullin.
Kanazawa H; Kawaguchi T; Fujii T; Shoji S; Hirata K; Kudoh S; Kurihara N; Yoshikawa J
Thorax; 1996 Dec; 51(12):1199-202. PubMed ID: 8994515
[TBL] [Abstract][Full Text] [Related]
6. Lack of adrenomedullin on antigen-induced bronchoconstriction in guinea pigs in vivo.
Ishiura Y; Fujimura M; Nobata K; Myou S; Amemiya T; Kurashima K
Life Sci; 2003 Mar; 72(17):1963-72. PubMed ID: 12597995
[TBL] [Abstract][Full Text] [Related]
7. Calcitonin gene-related peptide antagonizes the protective effect of adrenomedullin on histamine-induced bronchoconstriction.
Kanazawa H; Kawaguchi T; Kamoi H; Fujii T; Kudoh S; Hirata K; Kurihara N; Yoshikawa J
Clin Exp Pharmacol Physiol; 1996; 23(6-7):472-5. PubMed ID: 8800568
[TBL] [Abstract][Full Text] [Related]
8. Adrenomedullin inhibits ovalbumin-induced bronchoconstriction and airway microvascular leakage in guinea-pigs.
Ohbayashi H; Suito H; Yoshida N; Ilto Y; Kume H; Yamaki K
Eur Respir J; 1999 Nov; 14(5):1076-81. PubMed ID: 10596693
[TBL] [Abstract][Full Text] [Related]
9. Paracrine effects of PAMP and adrenomedullin on the human adrenal H295R cell line: PAMP but not adrenomedullin stimulates DHEA secretion.
Thomson LM; Kapas S; Hinson JP
Regul Pept; 2003 Apr; 112(1-3):3-7. PubMed ID: 12667619
[TBL] [Abstract][Full Text] [Related]
10. Proadrenomedullin NH(2)-terminal 20 peptide, a new product of the adrenomedullin gene, inhibits norepinephrine overflow from nerve endings.
Shimosawa T; Ito Y; Ando K; Kitamura K; Kangawa K; Fujita T
J Clin Invest; 1995 Sep; 96(3):1672-6. PubMed ID: 7657838
[TBL] [Abstract][Full Text] [Related]
11. [Adrenomedullin and related peptides].
Kitamura K
Nihon Yakurigaku Zasshi; 1998 Sep; 112(3):137-46. PubMed ID: 9793067
[TBL] [Abstract][Full Text] [Related]
12. The vasorelaxant effect of adrenomedullin, proadrenomedullin N-terminal 20 peptide and amylin in human skin.
Hasbak P; Eskesen K; Lind H; Holst J; Edvinsson L
Basic Clin Pharmacol Toxicol; 2006 Aug; 99(2):162-7. PubMed ID: 16918718
[TBL] [Abstract][Full Text] [Related]
13. Proadrenomedullin NH2-terminal peptide (PAMP)(12-20) has vasodepressor activity in the rat and cat.
Fry RC; Champion HC; Lawrence TC; Murphy WA; Coy DH; Kadowitz PJ
Life Sci; 1997; 60(10):PL161-7. PubMed ID: 9064471
[TBL] [Abstract][Full Text] [Related]
14. [Effects of adrenomedullin and proadrenomedullin N-terminal 20 peptide, alone or in combination, on the rat hearts in vitro].
Yang J; Li J; Geng B; Ren Y; Tang C
Beijing Da Xue Xue Bao Yi Xue Ban; 2003 Dec; 35(6):561-5. PubMed ID: 14710244
[TBL] [Abstract][Full Text] [Related]
15. Effects of adrenomedullin and PAMP on adrenal catecholamine release in dogs.
Masada K; Nagayama T; Hosokawa A; Yoshida M; Suzuki-Kusaba M; Hisa H; Kimura T; Satoh S
Am J Physiol; 1999 Apr; 276(4):R1118-24. PubMed ID: 10198393
[TBL] [Abstract][Full Text] [Related]
16. Adrenomedullin and proadrenomedullin N-terminal 20 peptide induce histamine release from rat peritoneal mast cell.
Yoshida M; Yoshida H; Kitaichi K; Hiramatsu K; Kimura T; Ito Y; Kume H; Yamaki K; Suzuki R; Shibata E; Hasegawa T; Takagi K
Regul Pept; 2001 Sep; 101(1-3):163-8. PubMed ID: 11495692
[TBL] [Abstract][Full Text] [Related]
17. Decrease of TSH levels and epithelium/colloid ratio in rat thyroid glands following administration of proadrenomedullin N-terminal peptide (12-20).
Ginda WJ; Nowak KW; Malendowicz LK
Horm Metab Res; 2000 Jan; 32(1):10-4. PubMed ID: 10727007
[TBL] [Abstract][Full Text] [Related]
18. Hypotensive effect of a newly identified peptide, proadrenomedullin N-terminal 20 peptide.
Shimosawa T; Fujita T
Hypertension; 1996 Sep; 28(3):325-9. PubMed ID: 8794811
[TBL] [Abstract][Full Text] [Related]
19. Proadrenomedullin N-terminal 20 peptide (PAMP) stimulates aldosterone secretion by the intact rat adrenal glomerulosa by a cAMP-dependent mechanism.
Thomson LM; Kapas S; Hinson JP
FEBS Lett; 1998 Jul; 432(1-2):37-9. PubMed ID: 9710246
[TBL] [Abstract][Full Text] [Related]
20. Elevation of circulating proadrenomedullin-N terminal 20-peptide in thyrotoxicosis.
Taniyama M; Kitamura K; Ban Y; Sugita E; Ito K; Katagiri T
Clin Endocrinol (Oxf); 1997 Mar; 46(3):271-4. PubMed ID: 9156034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
